Evidence map›Paper›PMID 42253922›Full record

ReviewMedComm2026

Progress in Natural Products Target Discovery Technology.

Qiyuan Pan, Xiao Yuan, Jinmei Jin, Xin Luan, Cheng Luo, Hongzhuan Chen, Weidong Zhang, Hao Zhang

Abstract readReview
In one paragraph

Review in MedComm, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Qiyuan PanShanghai Frontiers Science Center of TCM Chemical Biology Institute of Interdisciplinary Integrative Medicine Research and Shuguang Hospital Shanghai University of Traditional Chinese Medicine Shanghai China.ORCID https://orcid.org/0009-0005-2567-3206
Xiao YuanShanghai Frontiers Science Center of TCM Chemical Biology Institute of Interdisciplinary Integrative Medicine Research and Shuguang Hospital Shanghai University of Traditional Chinese Medicine Shanghai China.ORCID https://orcid.org/0009-0008-5940-7602
Jinmei JinShanghai Frontiers Science Center of TCM Chemical Biology Institute of Interdisciplinary Integrative Medicine Research and Shuguang Hospital Shanghai University of Traditional Chinese Medicine Shanghai China.ORCID https://orcid.org/0000-0002-5948-5001
Xin LuanShanghai Frontiers Science Center of TCM Chemical Biology Institute of Interdisciplinary Integrative Medicine Research and Shuguang Hospital Shanghai University of Traditional Chinese Medicine Shanghai China.ORCID https://orcid.org/0000-0003-3674-256X
Cheng LuoState Key Laboratory of Drug Research Shanghai Institute of Materia Medica Chinese Academy of Sciences Shanghai China.ORCID https://orcid.org/0000-0003-3864-8382
Hongzhuan ChenShanghai Frontiers Science Center of TCM Chemical Biology Institute of Interdisciplinary Integrative Medicine Research and Shuguang Hospital Shanghai University of Traditional Chinese Medicine Shanghai China.ORCID https://orcid.org/0000-0002-5367-2949
Weidong ZhangShanghai Frontiers Science Center of TCM Chemical Biology Institute of Interdisciplinary Integrative Medicine Research and Shuguang Hospital Shanghai University of Traditional Chinese Medicine Shanghai China.ORCID https://orcid.org/0000-0002-2433-6823
Hao ZhangShanghai Frontiers Science Center of TCM Chemical Biology Institute of Interdisciplinary Integrative Medicine Research and Shuguang Hospital Shanghai University of Traditional Chinese Medicine Shanghai China.ORCID https://orcid.org/0000-0002-6166-2089

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Natural products, owing to their unique biological activities, possess the ability to interact with specific target proteins or regulatory networks, representing a valuable source of innovative drug candidates. However, target identification remains a major bottleneck in natural product-based drug discovery, largely because of the chemical complexity of natural products and the heterogeneity of biological systems. To address these challenges, various complementary strategies have been developed, including experimental strategies such as chemical proteomics, and computational methods such as artificial intelligence-driven methods. Nevertheless, reliably advancing a candidate protein hit to a therapeutically relevant and physiologically validated target remains a critical challenge. Focusing on technologies for natural product target discovery, this review systematically summarizes the principles, methodologies, and practical applications of current approaches. Through representative case studies, we further propose a reusable integrated experimental-computational workflow and illustrates how key targets and their modes of action can be identified in real-world research scenarios. In addition, we discuss common technical and conceptual bottlenecks encountered during target discovery and proposes potential countermeasures. The review provides an actionable reference framework for natural product target identification, with the goal of reducing false-positive findings and fragmented evidence, thereby improving the robustness of mechanism-oriented studies and facilitating subsequent translational research.

Indexed as

artificial intelligencedrug discoverymolecular probesnatural productstarget identification

Identifiers

PMID42253922
PMCPMC13239285

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.